Mafenide microbiology: Difference between revisions
Jump to navigation
Jump to search
(Blanked the page) |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Mafenide}} | |||
{{CMG}}; {{AE}} {{chetan}} | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = MAFENIDE ACETATE POWDER, FOR SOLUTION [PAR PHARMACEUTICAL COMPANIES, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e48cc935-2058-48c0-9281-b8b919629493 | publisher = | date = | accessdate = }}</ref> | |||
==References== | |||
{{Reflist}} | |||
{{FDA}} | |||
[[Category:Antibiotics]] | |||
[[Category:Wikinfect]] | |||
Latest revision as of 05:00, 9 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
References
Adapted from the FDA Package Insert.